Skip to content
Open access

Antiviral sugar baits to reduce arbovirus transmission: a proof-of-concept study

Sep 2026 · bioRxiv · 0 citations · 27 references
Biology

TL;DR

Findings provide proof-of-concept for AVSBs as a novel strategy to reduce arbovirus transmission by targeting viral replication within the mosquito vector, suggesting that AVSBs could complement existing arbovirus control measures.

Abstract

Dengue virus (DENV) and chikungunya virus (CHIKV) remain major global health threats, yet approved antiviral therapies are lacking. Antiviral sugar baits (AVSBs) represent a novel transmission-blocking strategy that exploits the natural sugar-feeding behaviour of mosquitoes to deliver antiviral compounds directly to the mosquito vector. In this study, we evaluated the antiviral efficacy of AVSBs containing JNJ-A07, β-D-N4-hydroxycytidine (NHC, EIDD-1931), molnupiravir (MPV), and 4′-fluorouridine (4′FlU) in Aedes aegypti mosquitoes. An ex vivo mosquito gut model was used to select antiviral concentrations and to assess the ability of 4′FlU to reach the mosquito midgut following sugar feeding. AVSBs were subsequently evaluated for their effects on mosquito attractiveness, longevity, fecundity, and fertility, as well as their ability to suppress DENV and CHIKV infection in vivo. 4′FlU potently inhibited CHIKV replication in ex vivo mosquito guts and retained antiviral activity following sugar-bait administration. None of the antiviral compounds affected mosquito attraction to the bait, while only modest and compound-specific effects on mosquito fitness were observed. AVSBs containing JNJ-A07 significantly reduced DENV infection and dissemination, whereas 4′FlU-containing AVSBs significantly reduced CHIKV infection and viral loads. In contrast, NHC- and MPV-containing AVSBs did not exhibit antiviral activity in vivo. Collectively, these findings provide proof-of-concept for AVSBs as a novel strategy to reduce arbovirus transmission by targeting viral replication within the mosquito vector, suggesting that AVSBs could complement existing arbovirus control measures.

Read PDF

Similar papers

Open access Sep 2026

Solanaceae-Derived Spirostane Saponins Inhibit Dengue Virus Replication and Viral Protein Expression and Exhibit Activity Against Multiple Arboviruses.

Findings identify spirostane saponins as promising antiviral scaffolds as promising antiviral scaffolds and support their further development as broad-spectrum antiviral agents.

E. Jiménez-Posada, O. M. Mosquera-Martínez, Sara M. Robledo et al. · 0 citations
Sep 2026

Unveiling the antiviral mechanism of A4S7: a synthetic antimicrobial peptide targeting dengue and other mosquito-borne enveloped virus infections.

The synthetic AMP A4S7 was investigated, which effectively inhibited DENV-2 RNA and protein expression and reduced viral progeny production at specified concentrations without exhibiting cytotoxicity in Vero cells, and found the α-helical structure of A4S7 was found to be crucial for its antiviral activity.

Ting-Chun Lin, Jeng-Wei Lu, Chia-Hsin Liu et al. · 0 citations
Review Open access Oct 2026

Zika virus Pathogenesis and Targeted Intervention Strategies

The molecular mechanisms by which multiple ZIKV proteins synergistically regulate pathogenic processes are summarized and the current research basis and response strategies for flavivirus ADE are reviewed, and unresolved scientific questions are outlined.

Liang-Peng Suo, Hai-Zhen Fan, Qiong Wu et al. · 0 citations
Review Open access Sep 2026

Antiviral responses of Aedes mosquitoes to Old World alphaviruses.

Aedes (Ae.) aegypti and Ae. albopictus are efficient vectors of medically important Old World alphaviruses including chikungunya virus. In contrast to the well-characterized responses to orthoflavivirus infections, antiviral defense against alphaviruses in Aedes mosquitoes remains comparatively underexplored. This revi...

Jie-Ong Yin, Y. Chan, Wenn-Chyau Lee et al. · 0 citations
Open access Aug 2026

Investigation of the antiviral activity of Carica papaya L. leaf extract against dengue virus serotype 2 (DENV-2) in Vero cells

Limited antiviral activity against dengue virus serotype 2 under the tested conditions is indicated and support further work using wider concentration ranges and fractionation of its bioactive constituents are supported.

Maulidia Fitri Rusfandi, T. H. Sucipto, R. Saputri et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.